source
- Sanofi receives FDA clearance for Infilbray, first pill to treat neurological symptoms of Type 3 Gaucher diseaseSanofi received FDA clearance for Infilbray, a once-daily pill for Type 3 Gaucher disease in adults and children weighing at least 15 kilograms. The drug, inherited from Sanofi’s 2011 acquisition…
- Lawmakers push for stronger U.S. biotech support to stay ahead of ChinaMembers of the congressional Biotech Caucus told reporters that Washington must act quickly to boost the U.S. biotech sector and keep it ahead of China. They called for increased funding, streamli…